The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic ...

Employers are using transparency data to try to slow growth of their healthcare costs, and "the last thing you want to do is ...

ORLANDO -- Utilization of a "total telemedicine pathway" for inflammatory bowel disease (IBD) surgery saved a considerable ...

A diet low in omega-6 and enriched with omega-3 fatty acids and fish oil for prostate cancer patients on active surveillance ...

When individuals in high-risk groups do contract RSV, "there is a good chance" of issues like heart failure exacerbations, ...

Brain metastases are a common problem in patients with EGFR -mutated non-small cell lung cancer (NSCLC), occurring in about ...

We lived in India when I was a child, and I also grew up with the idea that there were parts of the world where vaccines were ...

A retrospective analysis presented at the American Society of Hematology annual meeting looked at multiple myeloma patients' ...

The FDA rejected the long-acting GLP-2 analog glepaglutide as a treatment for patients with short bowel syndrome, calling for ...

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...